Rapamycin 53123-88-9
29 Inquiries
53123-88-9
shanghai
as request
2024-01-10
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Rapamycin
Other Name:Rapamycin;23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rapamycin deriv.;Antibiotic AY 22989;[3S-[3R*[S*(1R*,3S*,4S*)],6S*,7E,9S*,10S*,12S*,14R*,15E,17E,19E,21R*,23R*,26S*,27S*,34aR*]]-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone;23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-,[3S-[3R*[S*(1R*,3S*,4S*)],6S*,7E,9S*,10S*,12S*,14R*,15E,17E,19E,21R*,23R*,26S*,27S*,34aR*]]-;(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone;AY 22989;(-)-Rapamycin;Sirolimus;SIIA 9268A;Rapamune;Rapammune;RPM;NSC 226080;RAPA;Wy 090217;Cypher;Nab rapamycin;Supralimus;14S-Rapamycin;Cypher Bx Velocity;PNP-sirolimus;DE 109;MS-RO01;MS-RO02;MS-RO03;Perceiva;Rapamysin;SVP-R;1179372-35-0;1189166-54-8;1233221-34-5;1353039-01-6
CAS No.:53123-88-9
Molecular Formula:C51H79NO13
InChIKeys:InChIKey=QFJCIRLUMZQUOT-HPLJOQBZSA-N
Molecular Weight:914.18
Exact Mass:914.17
EC Number:262-640-9
HScode:2942000000
Categories:
Characteristics-
PSA:
195
XLogP3:6
Appearance:yellow solid
Density:1.2±0.1 g/cm3
Melting Point:183-185 °C
Boiling Point:973°C at 760 mmHg
Flash Point:87 °C
Refractive Index:1.551
Water Solubility:soluble in DMSO at 50mg/ml or methanol at 25mg/ml. soluble in alcohol, dimethyl sulfoxide and dimethyl formamide. Insoluble in water.ethanol: soluble 2 MM
Storage Conditions:-20°C
Vapor Pressure:0.56 hPa ( 20 °C)
Toxicity:LD50 in mice (mg/kg): 600 i.p.; >2,500 orally (Vézina)
Specific rotation:D25 -58.2° (methanol)
Hazard IdentificationClassification of the substance or mixture
Carcinogenicity, Category 2
Reproductive toxicity, Category 2
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H351 Suspected of causing cancer
H361 Suspected of damaging fertility or the unborn child
H372 Causes damage to organs through prolonged or repeated exposure
Precautionary statement(s) Prevention P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS
-
Location:
Room 1623,Building A, ZhongqiaoCenter,Goverment District,Hefei city,Anhui Province,China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2019
-
-
Inquiry History29 Inquiries
Country Product Purchase Quantity Date Posted 
United States
Supply Medical Grade High Purity Rapamycin Powder CAS 53123-88-9 Rapamycin
100 G Aug 16, 2023
United States
Raw Pharmaceutical Grade Material Rapamycin Powder CAS 53123-88-9 with High Purity
100 G Jul 6, 2023 
Hungary
Raw Pharmaceutical Grade Material Rapamycin Powder CAS 53123-88-9 with High Purity
100 G Nov 20, 2023 
India
Raw Pharmaceutical Grade Material Rapamycin Powder CAS 53123-88-9 with High Purity
1000 MT Nov 18, 2023 
Germany
Raw Pharmaceutical Grade Material Rapamycin Powder CAS 53123-88-9 with High Purity
100 G Sep 7, 2023
United States
TNJONE High quality GMP Certificated 99% Purity Sirolimus Rapamycin 53123-88-9 in Stock
1 G Jan 1, 2025
United States
Rapamycin Powder
2 KG Aug 25, 2023 
Paraguay
Rapamycin Sirolimus Powder
1 G Feb 21, 2024
India
Rapamycin
1 MT Feb 12, 2026
India
Rapamycin
1.00 KG Jan 26, 2024
United States
Rapamycin
50 MG Apr 17, 2026
United States
rapamycin
100 G Sep 27, 2025 
Philippines
Rapamycin
5 G Feb 10, 2025 
Australia
Rapamycin
99 KG Nov 3, 2024
United States
Rapamycin
10 MT May 22, 2024 
Canada
Rapamycin
1 KG Jan 24, 2025
United States
Rapamycin
1 KG Nov 27, 2024
United States
rapamycin
1 G Jul 12, 2024
India
Rapamycin
1 KG Jun 28, 2024
United States
Rapamycin
1 KG Apr 14, 2025 Post an enquiry for this product